[Federal Register Volume 75, Number 128 (Tuesday, July 6, 2010)]
[Notices]
[Pages 38819-38821]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-16101]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 75 FR 22821-29, dated April 30, 2010) is 
amended to reflect the reorganization of the Division of Blood 
Disorders within the National Center on Birth Defects and Developmental 
Disabilities, Office of Noncommunicable Diseases, Injury and 
Environmental Health, Centers for Disease Control and Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Delete in its entirety the title and function statement for the 
Office of the Director (CUBD1) and insert the following.
    Office of the Director (CUBD1). (1) Provides leadership and 
guidance on strategic planning and implementation,

[[Page 38820]]

program priority setting, and policy development, to advance the 
mission of the Division of Blood Disorders, NCBDDD and CDC; (2) 
develops goals, objectives, and budget; monitors progress and 
allocation of resources, and reports accomplishments, future 
directions, and resource requirements; (3) facilitates scientific, 
policy and program collaboration among divisions and centers, and 
between CDC and other Federal/non-Federal partners; (4) promotes 
advancement of science throughout the division, supports program 
evaluation, and ensures that research meets the highest standards in 
the field; (5) provides medical expertise and consultation to planning, 
projects, policies and program activities; (6) advises the Office of 
the Director of NCBDDD on matters relating to prevention of 
complications due to blood disorders and coordinates division responses 
to requests for technical assistance or information on activities 
supported by the division; (7) develops and produces communications 
tools and public affairs strategies to meet the needs of division 
programs and mission; (8) represents the division at official 
professional and scientific meetings, both within and outside of CDC; 
(9) applies evaluation and prevention effectiveness functions in the 
assessment of blood disorder programs, projects and activities; (10) 
develops, implements and evaluates long term plans for surveillance, 
research and prevention activities pertaining to blood disorders; and 
(11) drafts and disseminates reports of future plans and needs to 
inform policy.
    After the Office of the Director (CUBD1) Division of Blood 
Disorders, National Center on Birth Defects and Developmental 
Disabilities, Office of Noncommunicable Diseases, Injury and 
Environmental Health, Centers for Disease Control and Prevention, 
insert the following:
    Epidemiology and Surveillance Branch (CUBDB). (1) Provides 
scientific leadership in the design and implementation of monitoring 
systems as well as designs and conducts epidemiologic and genetic 
research to identify causes, risk factors and complications of blood 
disorders in affected populations; (2) designs and manages surveillance 
systems to evaluate the incidence, morbidity, and mortality associated 
with blood diseases and disorders; (3) plans, develops and coordinates 
special surveys and populations studies to monitor and assess the 
complications of blood disorders; (4) designs and implements studies 
using surveillance data to identify risk factors for the complications 
of blood disorders, and evaluates the effectiveness of the prevention 
activities; (5) provides epidemiologic and medical consultation and 
technical assistance, including epidemic aids to State and local health 
departments, other governmental agencies, and other public and private 
institutions in the investigation of blood disorders and related 
complications; (6) designs and implements studies to evaluate the 
effectiveness of implemented prevention strategies in the treatment 
centers; (7) works closely with internal and external organizations in 
applying prevalence and incidence data to target and evaluate programs 
to prevent the complications of blood diseases and chronic hereditary 
disorders; (8) publishes findings and advances arising out of 
surveillance and epidemiologic research to the scientific and public 
health communities; (9) provides training services to States, 
localities, and other countries in investigation, diagnosis, 
prevention, and control of blood diseases and chronic hereditary 
disorders; (10) assists in designing, implementing, and evaluating 
prevention and counseling programs for persons and their families with 
chronic blood diseases and selected chronic hereditary disorders; (11) 
designs, implements and coordinates the prevention and surveillance 
activities of specialized Federally funded prevention centers organized 
to prevent the complications of blood diseases and chronic hereditary 
disorders; (12) conducts and supports both qualitative and quantitative 
research to expand the knowledge base related to blood disorders across 
the lifespan; and (13) collaborates with laboratory research branch and 
prevention research branch and incorporates the findings of these 
branches' activities which leads to prevention of complications of 
blood disorders.
    Laboratory Research Branch (CUBDC). (1) Identifies new genetic 
markers of risk factors and clotting defects for affected groups; (2) 
provides reference laboratory diagnosis for multi-site epidemiologic 
and surveillance studies; (3) develops techniques and interpretation 
methods to improve molecular and coagulation diagnosis; (4) provides 
diagnostic support for epidemiologic studies and epidemic aids on 
emerging blood disorders and chronic hereditary disorders; (5) 
determines the mechanisms of pathogenesis and complications of blood 
disorders and chronic hereditary disorders; (6) conducts research and 
provides reference services on diagnostic techniques for blood 
disorders and chronic hereditary disorders; (7) conducts research to 
improve laboratory methodologies and materials; (8) where appropriate, 
maintains the national reference laboratory for blood disorders and 
chronic hereditary disorders; (9) works closely with entities and 
organizations within the agency and organizations external to the 
agency to provide laboratory services in support of projects whose 
primary aim is to prevent and reduce complications associated with 
blood disorders and chronic hereditary disorders; and (10) publishes 
findings and advances arising out of surveillance and epidemiologic 
research to the scientific and public health communities.
    Prevention Research and Informatics Branch (CUBDD). (1) Performs 
health services research; (2) translates and evaluates the latest 
scientific advances from surveillance, epidemiology and laboratory 
support into enhanced delivery of care, prevention services, and 
information for affected populations; (3) develops, implements, 
evaluates and disseminates education and communication interventions 
that seek to identify and educate affected populations, providers and 
the public on health risks, protective factors and measures of 
effectiveness of health promotion activities and prevention of 
complications related to blood disorders; (4) collects, analyzes and 
prepares reports to document the prevalence and incidence of blood 
disorders and related complications and provides this information to 
affected populations through reports, publications, and public access 
data sets; (5) supports public health analysis to include facilitating 
data collection, data management, data manipulation, analysis, project 
reporting and presentation; (6) coordinates partnership activities; (7) 
assesses informatics needs and develops strategies to ensure accurate 
collection of data related to blood disorders and the division's 
activities; (8) conducts applied research to develop, evaluate, improve 
and standardize public information systems and educational modules 
which support the prevention of complications from blood disorders; (9) 
develops and maintains systems for collection, processing, validation, 
storage and dissemination of the highest quality information to study 
and monitor blood disorders; (10) disseminates findings and advances 
arising out of surveillance and epidemiologic research to the 
scientific and public health communities, and the

[[Page 38821]]

general public; (11) collaborates with and provides technical 
assistance, consultation, and training to local, State, Federal, and 
international agencies, universities and governmental and non-
governmental organizations on blood disorders and health related 
issues; (12) collaborates with local, State, Federal, and international 
agencies, and appropriate governmental and non-governmental 
organizations to develop, review, and implement policies that advance 
the health of people with blood disorders across the lifespan; (13) 
collaborates with funded non-governmental agencies to disseminate best 
practices, identify areas of need, facilitate development and 
distribution of educational materials, and provide informational 
resources to States and affected populations and their caregivers; and 
(14) develops informatics related trainings and communicates 
informatics changes to external partners.

    Dated: June 21, 2010.
William P. Nichols,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2010-16101 Filed 7-2-10; 8:45 am]
BILLING CODE 4160-18-M